COMP <GO>
INGN vs SMTI // EV/EBITDA & P/E VALUATION
Inogen Inc (NASDAQ) VS. Sanara MedTech Inc. (NASDAQ) • 15-METRIC TALLY: INGN 1
— SMTI 10
■ METRIC PARITY
LAST: $7.26 (+0.14%) • MKT CAP: $192.7M
valuation
—
LAST: $32.92 (+0.11%) • MKT CAP: $302.4M
valuation
29.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INGN VS. SMTI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INGN | SMTI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 52.20% | 92.70% | -40.50 | SMTI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.00% | 16.30% | -43.30 | SMTI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 29.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.13% | 0.71% | -7.84 | SMTI | /fcf-yield <GO> |
| Operating Margin | -10.20% | 7.10% | -17.30 | SMTI | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 36.40% | -28.70 | SMTI | /net-margins <GO> |
| Revenue Growth (YoY) | 5.90% | 19.00% | -13.10 | SMTI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.46 | 3.25 | -1.79 | SMTI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | SMTI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.6 | 27.3 | +34.30 | INGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 7.9x | 6.8x | +1.10 | SMTI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $192.7M | $302.4M | -$109.8M | SMTI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INGN REV | SMTI REV | INGN GROSS % | SMTI GROSS % | INGN FCF | SMTI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $295.3M | $103.1M | 52.2% | 92.7% | -$13.7M | $2.2M |
| FY 2024 | $278.8M | $86.7M | 55.5% | 90.6% | $2.6M | -$229.6K |
| FY 2023 | $251.6M | $65.0M | — | — | -$3.2M | -$3.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INGN // BETA —
SMTI // BETA —